Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
113.70
-0.45 (-0.39%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
August 02, 2024
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users.
Via
Investor's Business Daily
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth
August 02, 2024
Abbott Laboratories' growth rate may look comparable to Johnson & Johnson's, but in the long run it could become much higher.
Via
The Motley Fool
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Via
InvestorPlace
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
July 31, 2024
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Abbott Laboratories's Options Frenzy: What You Need to Know
July 26, 2024
Via
Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
July 26, 2024
Via
Benzinga
Behind the Scenes of Abbott Laboratories's Latest Options Trends
July 25, 2024
Via
Benzinga
Healthcare Stocks Are Coming On Strong In July Led By Biotech
July 29, 2024
The biotech rally gained momentum in July with rotation out of technology stocks.
Via
Talk Markets
Why Is NLS Pharmaceutics (NLSP) Stock Up 48% Today?
July 29, 2024
NLS Pharmaceutics stock is up on Monday after the company provided NLSP investors with details on a merger deal with Kadimastem.
Via
InvestorPlace
Why Is Cognition Therapeutics (CGTX) Stock Down 33% Today?
July 29, 2024
Cognition Therapeutics stock is down on Monday after CGTX investors read the latest data from a Phase 2 clinical trial report.
Via
InvestorPlace
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
July 29, 2024
ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage.
Via
InvestorPlace
3 High-Yield Dividend Stocks That Are Looking Super Hot
July 29, 2024
Discover high-yield dividend stocks offering solid returns. Learn about AbbVie, Target, and Abbott for reliable income and growth potential.
Via
InvestorPlace
Abbott, Integra LifeSciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 29, 2024
Via
Benzinga
US Stocks Look To Extend Gains Ahead Of Key Tech Earnings, FOMC Meeting: Analyst Says This 'Could Serve As A Fundamental Catalyst For Small And Mid-Cap'
July 29, 2024
Index futures trading indicates cautious optimism as traders anticipate a busy week, with a slew of earnings reports, the two-day Federal Open Market Committee meeting starting Tuesday, and Friday’s...
Via
Benzinga
Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula
July 29, 2024
This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. federal or state courts.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Is Beaten-Down Dexcom Stock a Buy on the Dip?
July 29, 2024
The market may have overreacted to a disappointing earnings report.
Via
The Motley Fool
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
July 29, 2024
Via
Benzinga
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
July 26, 2024
Dexcom's Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today.
Via
InvestorPlace
Better Buy: Abbott Laboratories vs. Intuitive Surgical
July 26, 2024
The medical technology business has been good for both companies, but which is right for your portfolio?
Via
The Motley Fool
3 High-Yielding Dividend Stocks That Can Help Bankroll Your Retirement Years
July 25, 2024
These stocks provide good yields and they don't come with much risk.
Via
The Motley Fool
Topics
Retirement
Exposures
Pension
7 Trustworthy Dividend Stocks to Steadily Build Your Portfolio
July 24, 2024
With political rumblings poised to make things exciting, investors may turn to the stability of trustworthy dividend stocks.
Via
InvestorPlace
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
July 22, 2024
The big pharma company's top drug is losing ground, but its dividend keeps rising.
Via
The Motley Fool
10 Best Dividend Growth Stocks to Buy and Hold Forever
July 21, 2024
Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.
Via
The Motley Fool
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
July 19, 2024
The Nasdaq tumbled amid chip woes.
Via
Investor's Business Daily
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
July 19, 2024
Abbott Laboratories is launching Lingo, an over-the-counter glucose monitoring device aimed at non-diabetic consumers, utilizing TV and guerilla marketing. CEO Robert Ford expects Lingo to become a...
Via
Benzinga
Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims
July 19, 2024
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the "Neutral" zone on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 Safe Stocks to Buy for Volatility Insurance
July 18, 2024
Although not known for their riveting narratives, these safe stocks to buy can offer protection amid a growth-sector shakedown.
Via
InvestorPlace
Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
July 18, 2024
ABT earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Are Abbott Laboratories Shares Trading Lower?
July 18, 2024
Shares of Abbott Laboratories (NYSE: ABT) are trading lower on Thursday following the company's announcement of its second-quarter 2024 financial results.
Via
Benzinga
Nasdaq Down Over 100 Points; Abbott Laboratories Earnings Beat Views
July 18, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.